TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,099,267 | +20.4% | 71,058 | +22.3% | 0.13% | +23.5% |
| Q2 2023 | $912,987 | -8.9% | 58,115 | -4.5% | 0.10% | -14.3% |
| Q1 2023 | $1,002,709 | +6.4% | 60,844 | +0.8% | 0.12% | -4.8% |
| Q4 2022 | $941,959 | +14.5% | 60,382 | -4.9% | 0.12% | +4.2% |
| Q3 2022 | $823,000 | +50.7% | 63,479 | +63.1% | 0.12% | +57.9% |
| Q2 2022 | $546,000 | +38.6% | 38,919 | +41.5% | 0.08% | +58.3% |
| Q1 2022 | $394,000 | +10.1% | 27,504 | +25.9% | 0.05% | -5.9% |
| Q3 2021 | $358,000 | +0.8% | 21,842 | +3.6% | 0.05% | -3.8% |
| Q2 2021 | $355,000 | +86.8% | 21,074 | +103.1% | 0.05% | +3.9% |
| Q1 2021 | $190,000 | +15.2% | 10,378 | +14.4% | 0.05% | +15.9% |
| Q4 2020 | $165,000 | – | 9,072 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |